Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 25(20)2020 Oct 16.
Artículo en Inglés | MEDLINE | ID: mdl-33081212

RESUMEN

Consumption of green tea (GT) and GT polyphenols has prevented a range of cancers in rodents but has had mixed results in humans. Human subjects who drank GT for weeks showed changes in oral microbiome. However, GT-induced changes in RNA in oral epithelium were subject-specific, suggesting GT-induced changes of the oral epithelium occurred but differed across individuals. In contrast, studies in rodents consuming GT polyphenols revealed obvious changes in epithelial gene expression. GT polyphenols are poorly absorbed by digestive tract epithelium. Their metabolism by gut/oral microbial enzymes occurs and can alter absorption and function of these molecules and thus their bioactivity. This might explain the overall lack of consistency in oral epithelium RNA expression changes seen in human subjects who consumed GT. Each human has different gut/oral microbiomes, so they may have different levels of polyphenol-metabolizing bacteria. We speculate the similar gut/oral microbiomes in, for example, mice housed together are responsible for the minimal variance observed in tissue GT responses within a study. The consistency of the tissue response to GT within a rodent study eases the selection of a dose level that affects tumor rates. This leads to the theory that determination of optimal GT doses in a human requires knowledge about the gut/oral microbiome in that human.


Asunto(s)
Antioxidantes/uso terapéutico , Microbioma Gastrointestinal/efectos de los fármacos , Neoplasias/dietoterapia , Té/química , Animales , Antioxidantes/química , Humanos , Ratones , Boca/microbiología , Neoplasias/microbiología , Neoplasias/patología , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Polifenoles/química , Polifenoles/uso terapéutico , Ratas , Roedores
2.
Sci Rep ; 8(1): 5873, 2018 04 12.
Artículo en Inglés | MEDLINE | ID: mdl-29651001

RESUMEN

Consumption of green tea (GT) extracts or purified catechins has shown the ability to prevent oral and other cancers and inhibit cancer progression in rodent models, but the evidence for this in humans is mixed. Working with humans, we sought to understand the source of variable responses to GT by examining its effects on oral epithelium. Lingual epithelial RNA and lingual and gingival microbiota were measured before and after 4 weeks of exposure in tobacco smokers, whom are at high risk of oral cancer. GT consumption had on average inconsistent effects on miRNA expression in the oral epithelium. Only analysis that examined paired miRNAs, showing changed and coordinated expression with GT exposure, provided evidence for a GT effect on miRNAs, identifying miRNAs co-expressed with two hubs, miR-181a-5p and 301a-3p. An examination of the microbiome on cancer prone lingual mucosa, in contrast, showed clear shifts in the relative abundance of Streptococcus and Staphylococcus, and other genera after GT exposure. These data support the idea that tea consumption can consistently change oral bacteria in humans, which may affect carcinogenesis, but argue that GT effects on oral epithelial miRNA expression in humans vary between individuals.


Asunto(s)
Antioxidantes/administración & dosificación , MicroARNs/genética , Mucosa Bucal/efectos de los fármacos , Neoplasias de la Boca/prevención & control , Té/química , Adulto , Antioxidantes/química , Carcinogénesis/efectos de los fármacos , Catequina/administración & dosificación , Epitelio/efectos de los fármacos , Epitelio/microbiología , Femenino , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Encía/efectos de los fármacos , Encía/microbiología , Humanos , Masculino , MicroARNs/efectos de los fármacos , Microbiota/efectos de los fármacos , Microbiota/genética , Persona de Mediana Edad , Mucosa Bucal/microbiología , Neoplasias de la Boca/genética , Neoplasias de la Boca/microbiología , Fumadores , Staphylococcus/efectos de los fármacos , Staphylococcus/patogenicidad , Streptococcus/efectos de los fármacos , Streptococcus/patogenicidad , Adulto Joven
3.
Mol Nutr Food Res ; 49(1): 43-51, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15538715

RESUMEN

Studies in cell culture and laboratory animals have shown that green tea and its major component, epigallocatechin-3-gallate, inhibit cell growth and reduce tumor incidence. However, results of epidemiological studies have generated inconsistent, sometimes conflicting data regarding protection by green tea against human cancers. To clarify the findings of these laboratory studies in application to humans, we conducted a pilot intervention study with three heavy smokers (> 10 cigarettes/day) and three nonsmokers (never smokers) in order to evaluate the molecular and cellular effects of drinking green tea using human oral cells as an investigative tool. Green tea total extract (400-500 mg/cup, 5 cups/day) was administered in drinking water to the subjects for four weeks. Two oral cytology samples were taken weekly for measurements of tobacco carcinogen-induced DNA damage, including bulky adducts and oxidized bases, cell growth, DNA content, and apoptosis. The study showed that during the course of green tea administration smoking-induced DNA damage was decreased, cell growth was inhibited, and the percentage of cells in S phase was reduced, cells accumulated in G1 phase (cyclin D1 positive), DNA content became more diploid and less aneuploid, and p53, Caspase-3, and TUNEL, markers of apoptosis, were increased. The study, although preliminary, indicates that drinking green tea reduced the number of damaged cells in smokers by inducing cell growth arrest and apoptosis, a mechanism similar to that observed in cultured cells and animals. These results warrant a large-scale intervention trial to further verify the role of green tea in the prevention of oral cancer in smokers.


Asunto(s)
Boca/patología , Fumar/efectos adversos , , Adulto , Apoptosis , Camellia sinensis/química , Caspasa 3 , Caspasas/metabolismo , División Celular , ADN/análisis , Aductos de ADN/análisis , Daño del ADN , Fase G1 , Humanos , Etiquetado Corte-Fin in Situ , Persona de Mediana Edad , Boca/química , Neoplasias de la Boca/etiología , Neoplasias de la Boca/prevención & control , Proyectos Piloto , Extractos Vegetales/administración & dosificación , Fase S , Fumar/patología , Lengua/patología , Proteína p53 Supresora de Tumor/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA